Quality Adjustment for Health Care Spending on Chronic Disease: Evidence from Diabetes Treatment, 1999-2009

S-Tier
Journal: American Economic Review
Year: 2011
Volume: 101
Issue: 3
Pages: 206-11

Authors (5)

Karen N. Eggleston (Stanford University) Nilay D. Shah (not in RePEc) Steven A. Smith (not in RePEc) Ernst R. Berndt (not in RePEc) Joseph P. Newhouse (National Bureau of Economic Re...)

Score contribution per author:

1.609 = (α=2.01 / 5 authors) × 4.0x S-tier

α: calibrated so average coauthorship-adjusted count equals average raw count

Abstract

Although US health care expenditures reached 17.6 percent of GDP in 2009, quality measurement in this important service sector remains limited. Studying quality changes associated with 11 years of health care for patients with diabetes, we find that the value of reduced mortality and avoided treatment spending, net of the increase in annual spending, was $9,094 for the average patient. These results suggest that the unit cost of diabetes treatment, adjusting for the value of health outcomes, has been roughly constant. Since input prices have not been declining, our results are consistent with productivity improvement in health care.

Technical Details

RePEc Handle
repec:aea:aecrev:v:101:y:2011:i:3:p:206-11
Journal Field
General
Author Count
5
Added to Database
2026-01-25